Table 1.
Treatment/Action Taken/Presentation | Initial Presentation | 6 Weeks | 12 Weeks | 18 Weeks | 24 Weeks |
---|---|---|---|---|---|
L-T4 Tablet (Synthroid®) 125 µg | T4/T3 Compounded Medication | T4/T3 Compound at Escalated Dosing | T4/T3 Compound at Escalated Dosing | Started with Worsening GI Issues, Gastroparesis, and Vomiting | |
TSH, mIU/L (NR 0.45–4.50 mIU/L) | 5.30 | 4.65 | 6.50 | 2.60 | 7.42 |
Free T4, pmol/L (NR 10.55–22.78 pmol/L) | 16.60 | 16.60 | 18.53 | 24.07 | 19.82 |
Free T3 pmol/L (NR 3.39–6.16 pmol/L) | Not evaluated | 4.47 | 5.24 | 4.93 | 5.24 |
Abbreviations: GI, gastrointestinal; L-T4, levothyroxine; NR, normal range; T3, triiodothyronine; T4, thyroxine; TSH, thyroid-stimulating hormone.